Advertisement
Canada markets close in 1 hour 13 minutes
  • S&P/TSX

    21,866.07
    -145.65 (-0.66%)
     
  • S&P 500

    5,065.16
    -5.39 (-0.11%)
     
  • DOW

    38,449.23
    -54.46 (-0.14%)
     
  • CAD/USD

    0.7297
    -0.0024 (-0.32%)
     
  • CRUDE OIL

    82.84
    -0.52 (-0.62%)
     
  • Bitcoin CAD

    88,382.98
    -3,039.79 (-3.32%)
     
  • CMC Crypto 200

    1,397.00
    -27.10 (-1.90%)
     
  • GOLD FUTURES

    2,331.70
    -10.40 (-0.44%)
     
  • RUSSELL 2000

    1,990.29
    -12.35 (-0.62%)
     
  • 10-Yr Bond

    4.6600
    +0.0620 (+1.35%)
     
  • NASDAQ

    15,686.99
    -9.65 (-0.06%)
     
  • VOLATILITY

    16.04
    +0.35 (+2.23%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • CAD/EUR

    0.6821
    -0.0015 (-0.22%)
     

Stocks in play: Khiron Life Sciences Corp.

Has received endorsements and signed co-operation agreements with two of the largest and most recognized medical associations in the country: The Colombian Association of Internal Medicine and the Colombian Association of Neurology. As a result, Khiron becomes the first medical cannabis company in Colombia to be endorsed by two medical associations and to be in a position to directly introduce its brand to a national audience of almost 3,000 doctors. Khiron Life Sciences Corp. shares V.KHRN are trading up $0.02 at $1.14.